ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 172 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $271,000 | -35.9% | 3,900 | -29.1% | 0.00% | -25.0% |
| Q4 2020 | $423,000 | -18.0% | 5,500 | -20.3% | 0.00% | -33.3% |
| Q3 2020 | $516,000 | -15.5% | 6,900 | -28.9% | 0.01% | -14.3% |
| Q2 2020 | $611,000 | -44.0% | 9,700 | -62.7% | 0.01% | -53.3% |
| Q1 2020 | $1,092,000 | -22.7% | 26,000 | -16.4% | 0.02% | 0.0% |
| Q4 2019 | $1,413,000 | +16.5% | 31,100 | +17.4% | 0.02% | +7.1% |
| Q3 2019 | $1,213,000 | -18.9% | 26,500 | +3.9% | 0.01% | -17.6% |
| Q2 2019 | $1,495,000 | +53.6% | 25,500 | +17.5% | 0.02% | +54.5% |
| Q1 2019 | $973,000 | +9.6% | 21,700 | -4.8% | 0.01% | -8.3% |
| Q4 2018 | $888,000 | -20.3% | 22,800 | -5.8% | 0.01% | -7.7% |
| Q3 2018 | $1,114,000 | -19.9% | 24,200 | -24.1% | 0.01% | -23.5% |
| Q2 2018 | $1,391,000 | +10.4% | 31,900 | 0.0% | 0.02% | +13.3% |
| Q1 2018 | $1,260,000 | – | 31,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 505,670 | $34,487,000 | 7.23% |
| Asymmetry Capital Management, L.P. | 142,246 | $9,701,000 | 6.67% |
| Prosight Management, LP | 137,000 | $9,343,000 | 5.84% |
| Avoro Capital Advisors LLC | 4,075,000 | $277,915,000 | 4.84% |
| Integral Health Asset Management, LLC | 225,000 | $15,345,000 | 4.22% |
| First Light Asset Management, LLC | 617,124 | $42,088,000 | 2.52% |
| SECTORAL ASSET MANAGEMENT INC | 322,599 | $22,001,000 | 1.78% |
| Avidity Partners Management LP | 943,000 | $64,313,000 | 1.74% |
| DAFNA Capital Management LLC | 119,615 | $8,158,000 | 1.71% |
| Nicholas Investment Partners, LP | 298,247 | $20,340,000 | 1.28% |